<i>FADD</i> in Cancer: Mechanisms of Altered Expression and Function, and Clinical Implications
FADD was initially described as an adaptor molecule for death receptor-mediated apoptosis, but subsequently it has been implicated in nonapoptotic cellular processes such as proliferation and cell cycle control. During the last decade, FADD has been shown to play a pivotal role in most of the signal...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2019-09-01
|
| Series: | Cancers |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6694/11/10/1462 |
| _version_ | 1797708289835794432 |
|---|---|
| author | José L Marín-Rubio Laura Vela-Martín José Fernández-Piqueras María Villa-Morales |
| author_facet | José L Marín-Rubio Laura Vela-Martín José Fernández-Piqueras María Villa-Morales |
| author_sort | José L Marín-Rubio |
| collection | DOAJ |
| description | FADD was initially described as an adaptor molecule for death receptor-mediated apoptosis, but subsequently it has been implicated in nonapoptotic cellular processes such as proliferation and cell cycle control. During the last decade, FADD has been shown to play a pivotal role in most of the signalosome complexes, such as the necroptosome and the inflammasome. Interestingly, various mechanisms involved in regulating FADD functions have been identified, essentially posttranslational modifications and secretion. All these aspects have been thoroughly addressed in previous reviews. However, FADD implication in cancer is complex, due to pleiotropic effects. It has been reported either as anti- or protumorigenic, depending on the cell type. Regulation of <i>FADD</i> expression in cancer is a complex issue since both overexpression and downregulation have been reported, but the mechanisms underlying such alterations have not been fully unveiled. Posttranslational modifications also constitute a relevant mechanism controlling FADD levels and functions in tumor cells. In this review, we aim to provide detailed, updated information on alterations leading to changes in <i>FADD</i> expression and function in cancer. The participation of FADD in various biological processes is recapitulated, with a mention of interesting novel functions recently proposed for FADD, such as regulation of gene expression and control of metabolic pathways. Finally, we gather all the available evidence regarding the clinical implications of <i>FADD</i> alterations in cancer, especially as it has been proposed as a potential biomarker with prognostic value. |
| first_indexed | 2024-03-12T06:19:09Z |
| format | Article |
| id | doaj.art-d27212322df24b5a9e0e7c86de7ed763 |
| institution | Directory Open Access Journal |
| issn | 2072-6694 |
| language | English |
| last_indexed | 2024-03-12T06:19:09Z |
| publishDate | 2019-09-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Cancers |
| spelling | doaj.art-d27212322df24b5a9e0e7c86de7ed7632023-09-03T02:22:36ZengMDPI AGCancers2072-66942019-09-011110146210.3390/cancers11101462cancers11101462<i>FADD</i> in Cancer: Mechanisms of Altered Expression and Function, and Clinical ImplicationsJosé L Marín-Rubio0Laura Vela-Martín1José Fernández-Piqueras2María Villa-Morales3Institute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne NE2 4HH, UKDepartamento de Biología, Universidad Autónoma de Madrid, 28049 Madrid, SpainDepartamento de Biología, Universidad Autónoma de Madrid, 28049 Madrid, SpainDepartamento de Biología, Universidad Autónoma de Madrid, 28049 Madrid, SpainFADD was initially described as an adaptor molecule for death receptor-mediated apoptosis, but subsequently it has been implicated in nonapoptotic cellular processes such as proliferation and cell cycle control. During the last decade, FADD has been shown to play a pivotal role in most of the signalosome complexes, such as the necroptosome and the inflammasome. Interestingly, various mechanisms involved in regulating FADD functions have been identified, essentially posttranslational modifications and secretion. All these aspects have been thoroughly addressed in previous reviews. However, FADD implication in cancer is complex, due to pleiotropic effects. It has been reported either as anti- or protumorigenic, depending on the cell type. Regulation of <i>FADD</i> expression in cancer is a complex issue since both overexpression and downregulation have been reported, but the mechanisms underlying such alterations have not been fully unveiled. Posttranslational modifications also constitute a relevant mechanism controlling FADD levels and functions in tumor cells. In this review, we aim to provide detailed, updated information on alterations leading to changes in <i>FADD</i> expression and function in cancer. The participation of FADD in various biological processes is recapitulated, with a mention of interesting novel functions recently proposed for FADD, such as regulation of gene expression and control of metabolic pathways. Finally, we gather all the available evidence regarding the clinical implications of <i>FADD</i> alterations in cancer, especially as it has been proposed as a potential biomarker with prognostic value.https://www.mdpi.com/2072-6694/11/10/1462<i>fadd</i>chromosomal alterationsmutationspolymorphismstranscription factorsepigenetic regulationposttranslational modificationsgene expressionmetabolismclinical implications |
| spellingShingle | José L Marín-Rubio Laura Vela-Martín José Fernández-Piqueras María Villa-Morales <i>FADD</i> in Cancer: Mechanisms of Altered Expression and Function, and Clinical Implications Cancers <i>fadd</i> chromosomal alterations mutations polymorphisms transcription factors epigenetic regulation posttranslational modifications gene expression metabolism clinical implications |
| title | <i>FADD</i> in Cancer: Mechanisms of Altered Expression and Function, and Clinical Implications |
| title_full | <i>FADD</i> in Cancer: Mechanisms of Altered Expression and Function, and Clinical Implications |
| title_fullStr | <i>FADD</i> in Cancer: Mechanisms of Altered Expression and Function, and Clinical Implications |
| title_full_unstemmed | <i>FADD</i> in Cancer: Mechanisms of Altered Expression and Function, and Clinical Implications |
| title_short | <i>FADD</i> in Cancer: Mechanisms of Altered Expression and Function, and Clinical Implications |
| title_sort | i fadd i in cancer mechanisms of altered expression and function and clinical implications |
| topic | <i>fadd</i> chromosomal alterations mutations polymorphisms transcription factors epigenetic regulation posttranslational modifications gene expression metabolism clinical implications |
| url | https://www.mdpi.com/2072-6694/11/10/1462 |
| work_keys_str_mv | AT joselmarinrubio ifaddiincancermechanismsofalteredexpressionandfunctionandclinicalimplications AT lauravelamartin ifaddiincancermechanismsofalteredexpressionandfunctionandclinicalimplications AT josefernandezpiqueras ifaddiincancermechanismsofalteredexpressionandfunctionandclinicalimplications AT mariavillamorales ifaddiincancermechanismsofalteredexpressionandfunctionandclinicalimplications |